HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells.

Abstract
Chronic hepatitis B virus (HBV) infection is endemic to several populous areas of the world and is frequently complicated by hepatocellular carcinoma. Ribozymes can be designed to cleave target RNA sequences specifically and show promise for the treatment of HBV infection. Demonstration of intracellular inhibition of HBV gene expression, essential to developing therapeutic ribozymes, has been the aim of this investigation. We generated two vectors encoding hammerhead ribozymes that target the HBx region of HBV. Plasmids containing intact HBV sequences or a modification in which the preS2/S region was replaced by DNA encoding enhanced green fluorescent protein (EGFP) were used to test ribozyme action in transfected cells. Both ribozymes inhibited surface antigen secretion and EGFP expression similarly. The measurement of EGFP expression is convenient to assess ribozyme action in situ and effective targeting of HBV sequences that are common to all HBV transcripts is potentially useful to develop strategies to counter HBV infection.
AuthorsM Passman, M Weinberg, M Kew, P Arbuthnot
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 268 Issue 3 Pg. 728-33 (Feb 24 2000) ISSN: 0006-291X [Print] United States
PMID10679273 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2000 Academic Press.
Chemical References
  • DNA Primers
  • DNA, Complementary
  • Luminescent Proteins
  • RNA, Catalytic
  • Trans-Activators
  • Viral Regulatory and Accessory Proteins
  • hepatitis B virus X protein
  • Green Fluorescent Proteins
Topics
  • Base Sequence
  • Cell Line
  • DNA Primers (genetics)
  • DNA, Complementary (genetics)
  • Gene Expression (drug effects)
  • Genes, Viral
  • Genetic Vectors
  • Green Fluorescent Proteins
  • Hepatitis B virus (drug effects, genetics)
  • Hepatitis B, Chronic (therapy, virology)
  • Humans
  • Luminescent Proteins (genetics)
  • Molecular Sequence Data
  • RNA, Catalytic (genetics, pharmacology)
  • Trans-Activators (genetics)
  • Transfection
  • Viral Regulatory and Accessory Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: